distributions, rather than merely complementing predictions produced by the underlying algorithms with further information.
Conformal and Venn prediction have been successfully applied to many challenging real world problems in medicine, engineering, and other application areas. These methods have been extended to such settings as semi-supervised learning, anomaly detection, feature selection, outlier detection, change detection in streams, and active learning. Recent developments in collecting large volumes of data have also required their adjustment to handle "big data". An ongoing EU Horizon 2020 project on drug design has adopted conformal predictors as one of the main tools for selecting useful chemical compounds. Industrial companies have started applying conformal prediction, with a recent example being its use by AstraZeneca to accelerate the process of development of new drugs.
Overall, seven papers were accepted for this special issue after being reviewed by three (occasionally two) independent referees. The issue is divided into two parts. We are very grateful to the editors of Machine Learning and the journal's technical and production teams. We are also indebted to the Symposium sponsors: Royal Holloway University of London, Karolinska Institutet, KTH Royal Institute of Technology and AstraZeneca. Finally, our special thanks go to Yandex for their help and support.
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